HRT Financial LP bought a new position in shares of Seer, Inc. (NASDAQ:SEER – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 120,520 shares of the company’s stock, valued at approximately $699,000. HRT Financial LP owned approximately 0.19% of Seer as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also bought and sold shares of the company. Credit Suisse AG increased its position in Seer by 8.4% during the third quarter. Credit Suisse AG now owns 23,001 shares of the company’s stock worth $178,000 after buying an additional 1,774 shares during the last quarter. New York State Common Retirement Fund increased its position in Seer by 7.7% during the third quarter. New York State Common Retirement Fund now owns 31,766 shares of the company’s stock worth $246,000 after buying an additional 2,275 shares during the last quarter. Bank of New York Mellon Corp increased its position in Seer by 1.7% during the first quarter. Bank of New York Mellon Corp now owns 167,293 shares of the company’s stock worth $2,549,000 after buying an additional 2,734 shares during the last quarter. American International Group Inc. increased its position in Seer by 16.9% during the second quarter. American International Group Inc. now owns 24,145 shares of the company’s stock worth $216,000 after buying an additional 3,484 shares during the last quarter. Finally, MetLife Investment Management LLC increased its position in Seer by 14.7% during the third quarter. MetLife Investment Management LLC now owns 31,352 shares of the company’s stock worth $243,000 after buying an additional 4,026 shares during the last quarter. Institutional investors own 76.16% of the company’s stock.
Wall Street Analysts Forecast Growth
Separately, Morgan Stanley decreased their target price on Seer from $11.00 to $10.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 21st.
Seer Stock Up 3.3 %
Seer (NASDAQ:SEER – Get Rating) last posted its earnings results on Thursday, March 2nd. The company reported ($0.36) EPS for the quarter, beating the consensus estimate of ($0.42) by $0.06. The company had revenue of $4.60 million for the quarter, compared to the consensus estimate of $4.64 million. Seer had a negative return on equity of 20.62% and a negative net margin of 574.63%. Research analysts predict that Seer, Inc. will post -1.54 earnings per share for the current fiscal year.
Seer Profile
Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials.
See Also
- Get a free copy of the StockNews.com research report on Seer (SEER)
- Trading Channel Breakout in Lululemon Brought by Earnings
- What Should Investors Make of These 3 Dividend Cuts?
- Constellation Brands Taps into Growth: Analysts Bullish on Stock
- CrowdStrike: Another Tech Stock to Buy on the DipĀ
- Salesforce: Time to Snap it Up as the Market Buys the Dip?
Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.